Dendritic cell dysfunction and implications for dendritic cell-based therapy in colorectal cancer
Submitted: 27 June 2011
Accepted: 13 September 2011
Published: 2 November 2011
Accepted: 13 September 2011
Abstract Views: 822
PDF: 594
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Ethics Approval
Supporting Agencies
Vallop Josiassen, M., & Paulsson, K. (2011). Dendritic cell dysfunction and implications for dendritic cell-based therapy in colorectal cancer. Drugs and Therapy Studies, 1(1), e14. https://doi.org/10.4081/dts.2011.e14
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.